4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid ObesityAnorectal Diseases, Body Weight, Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Fissure in Ano, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anus disorder, cardiovascular disorder, constipation disorder, diarrheal disease, digestive system disorder, hemorrhoid, intestinal disorder, morbid obesity, nutritional disorder, obesity disorder, overnutrition, rectal disorder, vascular disorderNot yet recruitingNot stated2026-06-25NCT07668765
Low-Flow Anesthesia and Open-Heart SurgeryHemodynamics; Low-flow Anesthesia; Open-heart SurgeryRecruitingNot stated2026-05-27NCT07040735
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, erythropoietic protoporphyria, hepatic porphyria, hereditary disease, hereditary skin disorder, liver disorder, metabolic disease, porphyria, skin disorderRecruitingNot stated2026-05-05NCT07567131
Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLECongenital, Hereditary, and Neonatal Diseases and Abnormalities, Mucopolysaccharidosis III, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous mucinosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 3BEnrolling by invitationPhase 42023-08-09NCT05492799